Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia

Abstract Background The effects of lipid‐lowering drugs [including statins, ezetimibe, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors] on hyperlipidaemia have been established. Some may have treatment effects beyond their reported properties, offering potential opportunities fo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hongyan Jiang, Lulu Li, Xue Zhang, Jia He, Chuanhuai Chen, Ruimin Sun, Ying Chen, Lijuan Xia, Lei Wen, Yunxiang Chen, Junxiu Liu, Lijiang Zhang, Wanqiang Lv
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-12-01
coleção:	Journal of Cachexia, Sarcopenia and Muscle
Assuntos:	Mendelian randomization Older people Proprotein convertase subtilisin/kexin type 9 Sarcopenia Therapeutic target prediction
Acesso em linha:	https://doi.org/10.1002/jcsm.13575
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!